Blauvelt,  10/25/2018

Syringe Label Solution Supports Correct Dosing, Safe Dispensing

Schreiner MediPharm Develops Protective Label for Dosing Syringe by Raumedic

The dosing syringe in original condition with non-activated button (above), with the label protecting the button (middle) and with dose set after activating the button (below).

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has designed a protective label for a syringe system developed by polymer specialist Raumedic. The dosing syringe label supports exact dosage measurement of a medicine for children as part of a clinical trial. Potential dosage errors of the medication and false trial outcomes can thus be avoided.

Based on commonly used oral syringes for volumes of 1, 5 and 10 millileters, Raumedic’s dosing system reduces the risk of dosage errors through an adjustment button that fixes dosages upon first use. To prevent the button’s unintentional early activation, Schreiner MediPharm’s protective label wraps around the syringe and completely covers the button. In this fashion, the label functions as a visual barrier to the adjustment button, preventing healthcare staff from accidentally activating the mechanism prematurely.

Since the button becomes visible only after the initial dose has been drawn up and the label opened at the starter tab, accidental activation prior to this process is successfully deterred. Upon opening, a simple press locks the button, which presets the correct dose for subsequent administrations. Additionally, the label includes a reference to the user directions that should be read before fixing the dose.

This innovative design posed initial challenges for Schreiner MediPharm’s Clinical Trial Services team. The multilayer label had to ensure ease of use and be optimally adapted to the shape of the syringe. In addition, a specific stiffness and adhesion of the label was required. The tailored dosing syringe label enhances the safety of handling the dosing syringe and helps avoid dosage errors. This increases patient safety during clinical trials, supports medication compliance and addresses potential sources of error in risk assessment.

 

About Raumedic
Human health is at the core of Raumedic Group's business. The company specializes in processing medical-grade thermoplastic polymers and silicones at five production sites in Germany and the United States. As a partner of the international medical technology and pharmaceutical industry, the polymer specialist develops and produces customized components for customers, including tubing, catheters and molded parts as well as complex groups of components and systems for diagnostic and therapeutic uses. For the clinical areas of neuro-monitoring and traumatology, Raumedic produces high-precision pressure-measuring systems with microchip technology. In doing so, it plays a key role in safe patient care around the world. With 70 years of experience in the areas of extrusion, injection molding and assembly, the company with a global workforce of 800 people turns customer ideas into mature products. The foundation of this work is formed by a quality management system based on ISO 13485 and clean room manufacturing on an area of 107,000 square feet (10,000 square meters) based on ISO 14644 (class 7). Its global sales network and its own distribution companies in core markets ensure that medical and pharmaceutical customers as well as end users in hospitals and doctors’ offices have a high level of product availability at all times.

 

For further information, contact:
Schreiner MediPharm, a business unit of
Schreiner Group LP
300 Corporate Drive, Suite 10
Blauvelt, NY 10913
Phone (845) 848-9000
Fax  (845) 848-9041
info@schreiner-medipharm.com 
www.schreiner-medipharm.com